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Muscle founder cells regulate defasciculation and targeting of
motor axons in the Drosophila embryo
Matthias Landgraf*, Mary Baylies† and Michael Bate*
During Drosophila embryogenesis, motor axons leave
the central nervous system (CNS) as two separate
bundles, the segmental nerve (SN) and intersegmental
nerve (ISN). From these, axons separate (defasciculate)
progressively in a characteristic pattern, initially as
nerve branches and then as individual axons, to
innervate target muscles [1,2]. This pattern of branching
resembles the outgrowth and defasciculation of motor
axons from the neural tube of vertebrate embryos. The
factors that trigger nerve branching are unknown. In
vertebrate limbs, the branched innervation may depend
on mesodermal cues, in particular on the connective
tissues that organise the muscle pattern [3]. In
Drosophila, the muscle pattern is organised by specific
mesodermal cells, the founder myoblasts, which initiate
the development of individual muscles [4–6]. Founder
myoblasts fuse with neighbouring non-founder
myoblasts and entrain these to a specific muscle
programme, which also determines their innervation
[4,7]. In the absence of mesoderm, ISN and SN can
form, but motor axons fail to defasciculate from these
bundles [7]. The cue(s) for nerve branching therefore lie
within the mesoderm, most likely in the muscles and/or
in the precursor cells of the adult musculature [8]. Here,
we show that founder myoblasts are the source of the
cue(s) that are required to trigger defasciculation and
targeted growth of motor axons. Moreover, we found
that a single founder myoblast can trigger the
defasciculation of an entire nerve branch. This suggests
that the muscle field is structured into sets of muscles,
each expressing a common defasciculation cue for a
particular nerve branch.
Addresses: *Department of Zoology, Downing Street, Cambridge CB2
3EJ, UK. †Molecular Biology Program, Memorial Sloan Kettering Cancer
Center, 1275 York Avenue Box 310, New York, New York 10021, USA.
Correspondence: Matthias Landgraf
E-mail: ml10006@cus.cam.ac.uk
Received: 6 April 1999
Accepted: 23 April 1999
Published: 24 May 1999
Current Biology 1999, 9:589–592
http://biomednet.com/elecref/0960982200900589
© Elsevier Science Ltd ISSN 0960-9822
Results and discussion
We reasoned that founder myoblasts might provide the
cues for axonal defasciculation and targeted growth. To
test this, we used the fact that founder-cell segregation,
like the segregation of neuroblasts, depends on lateral
inhibition, which requires the functions of the neurogenic
genes. Loss of function of genes such as Notch or Delta
leads to an overproduction of founder-like cells in the
mesoderm at the expense of non-founder myoblasts
[9–11]. To inhibit segregation of founder cells and thereby
prevent muscle formation, we expressed activated Notch
[12] throughout the mesoderm from stage 10 onwards
(using the GAL4 system and 24BGAL4 as the mesoderm-
specific driver [13]). In these 24B–Notch* embryos, the
ectoderm developed relatively normally, but in the meso-
derm, muscle founders failed to form (Figure 1c–d).
Instead, rounded, unfused myoblasts accumulated and
expressed muscle myosin but did not fuse to form muscles
(Figure 1a,b). Strikingly, despite the presence of these
myoblasts, the behaviour of motor axons in these embryos
resembled that seen in twist mutant embryos, which lack
mesoderm: SN and ISN grew out but axons failed to
defasciculate and the nerves remained unbranched
(Figure 2a,b). Because we know that myoblast fusion is
Figure 1
Ectopic expression of activated Notch in the mesoderm suppressed
formation of founder myoblasts. Stage 16 (a,c) wild-type and
(b,d) 24B–Notch* embryos. (b) Ectopic expression of activated Notch
in the mesoderm suppressed founder-myoblast segregation. Anti-
myosin staining revealed that instead of syncytial muscles, seen in (a),
only unfused, rounded myoblasts formed in 24B–Notch* embryos (b).
(c) Vestigial is a nuclear marker for a subset of founder cells and
internal muscles (indicated by the arrow) [4,9,21]. Vestigial was also
expressed in a few cells in the CNS (indicated by the asterisk). (d) In
24B–Notch* embryos, Vestigial-positive founder cells rarely formed in
the mesoderm (0.5%; n = 200), but Vestigial expression in the CNS
(indicated by the asterisk) was not affected. We have obtained similar
results with other founder cell markers (S59 and Even-skipped).
Anterior is to the left, dorsal is uppermost. 









not required for normal patterns of nerve growth [7], this
experiment suggests that the founder cells are necessary
for the normal defasciculation and targeted growth of the
motor axons.
To show that founder myoblasts can trigger axon branch-
ing, we looked at segments of 24B–Notch* embryos in
which loss of founders was incomplete. In every case,
axons defasciculated from the principal nerve trunks and
innervated the remaining isolated muscles (Figure 2c,d;
n = 132 muscles in 79 of 154 hemisegments). Significantly,
the specificity of axon branching was maintained. As in
wild-type embryos, muscles that expressed the cell adhe-
sion molecule connectin were exclusively and reliably con-
tacted by connectin-expressing SN axons (data not shown;
n = 83 hemisegments) [14,15] and islet-τ-myc-expressing
ISNb axons [16] exclusively contacted their target ventral
muscles (n = 212 hemisegments). Moreover, in the
absence of ventral target muscles, ISNb axons projected
dorsally within ISN (Figure 2c–f; 98%, n = 63 hemiseg-
ments), suggesting that the default state of motor axons is
growth dorsally and that ISNb axons are normally
restricted to the ventral sector of the muscle field by
attraction to their target ventral muscles.
Mesodermally derived precursors of the adult musculature
(so-called ‘persistent Twist cells’ because they maintain
Twist expression) have also been implicated in directing
nerve branching [8] and their segregation was inhibited in
24B–Notch* embryos. We found that nerve branching
occurred in the absence of adult muscle precursors, but
only in response to founder myoblasts (n = 62 in 140
hemisegments) and those adult muscle precursors that did
form were rarely found at nerve branching points
(Figure 3; 6%; n = 31 muscles in 140 hemisegments). We
conclude that founder myoblasts not only contain the
information necessary to endow each muscle with its spe-
cific characteristics, but also provide the cues that induce
defasciculation and targeted growth of motor axons.
Normal defasciculation is progressive: ISNb defasciculates
from ISN and individual axons defasciculate from ISNb to
innervate their muscle targets [17,18]. To determine
whether founder cells simply act as targets for individual
axons or whether these cells can trigger the initial forma-
tion of entire nerve branches, we examined the behaviour
of ISNb, using the cell adhesion molecule fasciclin III as
an ISNb-specific marker [7,17]. The target muscles of
ISNb, which are ventral and express Vestigial, rarely
formed in our 24B–Notch* embryos, however (0.5%,
n = 200 hemisegments). We therefore studied embryos
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Figure 2
Muscle founder cells are required for peripheral nerve branching. Late
stage 16 (a) wild-type and (b) 24B–Notch* embryos stained with anti-
fasciclin II (anti-Fas II) to reveal motor axons. (b) Without target
muscles the main nerve trunks (ISN and SN) grow out and terminate
on sensory neurons (indicated by open arrowheads), but nerve
branches fail to form. In the anterior segment shown, the nerve branch
SNc has formed in response to a target muscle. In the central segment
shown, SNc has formed in response to ingrowing sensory axons. SNc
is the only nerve branch that can do so; this was seen in 16% of
segments (n = 154). (c–f) The islet-τ-myc (isl-τ-myc) reporter
construct labels ISNb, the ventral branch of ISN. (d,f) Without muscles,
ISNb remains fasciculated with ISN and projects past its ventral target
domain by late stage 16 (d) and past the lateral chordotonal organs
(Chord) into the dorsal domain by late stage 17 (f). Arrows indicate
ISNb growth cones. Unexpectedly, the anti-Myc serum stains nuclei of
muscles and peripheral glia in the 24B–Notch* background. (g,h) Late
stage 16 (g) wild-type and (h) Dmef2 mutant embryos double-stained
with anti-fasciclin III antibodies (anti-Fas III), which label ISNb axons,
and anti-Vestigial antibodies (anti-Vg), which label the nuclei of target
muscles of ISNb, indicated by brackets. Without target muscles
(posterior segment), ISNb remains fasciculated with ISN. In response
to even a single target founder myoblast (anterior segments), the entire
ISNb defasciculates (open arrows indicate ISNb–ISN branch points).
Anterior is to the left, dorsal is uppermost. The scale bar represents
15 µm. Asterisks in (a,b,d,f) indicate the CNS.
































































that were mutant for Dmef2, in which myoblast fusion fails
and the pattern of ventral muscle founders is variable
[19,20]: in some segments there are no founders and in
others single founders or groups of founders are formed
and can be identified by their expression of Vestigial
[4,9,21]. In Dmef2 mutant embryos, in the absence of
ventral Vestigial-expressing founders (n = 56 of 152
hemisegments), ISNb failed to defasciculate from ISN
and continued to grow dorsally, as in the 24B–Notch*
embryos. Strikingly, in these embryos, if even only a
single ventral Vestigial-expressing founder cell was
present (n = 85 of 152 hemisegments), ISNb defascicu-
lated as a bundle and grew to contact the founder
(Figure 2h). We conclude that muscle founders not only
provide the cues for targeted growth of individual axons
but also are necessary and sufficient to trigger the forma-
tion of major nerve branches. Thus, the muscle field
appears to be structured into sets of muscles, each
expressing a common defasciculation cue for a particular
nerve branch. Within each such set, muscle targets are
individually recognisable, presumably because of the
expression of further cues.
In vertebrate embryos, experiments suggest that the
muscle pattern is organised not by special myoblasts but
by connective tissues of mesodermal origin, which are
also thought to provide the necessary cues to direct the
pattern of peripheral nerve branching [3,22–24]. The
sequence of nerve branching also depends on reductions
in the mutual adhesiveness of axons within the motor
nerve (by polysialation of the neural cell adhesion mole-
cule N-CAM) [25,26]. The way in which defasciculation
is triggered, however, is not clear. In Drosophila, inter-
axonal adhesion is mediated by a number of neural cell
adhesion molecules (such as fasciclin II, fasciclin III and
connectin) and is antagonised by Beaten path, a protein
secreted by motor neuron growth cones and expressed at
high levels in motor neurons whose axons branch from
the main nerve trunks [27]. The fact that overexpression
of neural cell adhesion molecules [28], like the loss of
Beaten path expression [27], interferes with nerve
branching, mimicking the effects of removing founder
cells, indicates that the balance of adhesive forces is a
decisive factor in branch formation. We found that the
differential expression of beaten path mRNA was estab-
lished before contact with target muscles and was inde-
pendent of the presence of these muscles (data not
shown). Mutations in dptp69D, dptp99A and Dlar also
cause failures of nerve branching [29,30]. These genes
encode receptor tyrosine phosphatases whose extracellu-
lar domains may interact with ligands provided by
founder myoblasts and whose intracellular catalytic
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Figure 3
Persistent Twist cells (PTCs) are not required
for nerve branching. Late stage 16 (a) wild-
type and (b) 24B–Notch* embryos double-
stained with anti-fasciclin II antibodies, which
label motor axons, and anti-Twist antibodies,
which label nuclei. (a) PTCs (arrows) are
normally associated with nerve branches.
(b) Nerve branches do not form in response to
PTCs (arrow in the posterior segment) and
form only in response to target muscles
(bracket), even in the absence of PTCs
(anterior segment). Anterior is to the left, dorsal
is uppermost. The scale bar represents 11 µm.











The Drosophila neuromuscular system. Diagram of nerve branching
and body-wall muscle innervation in (a) wild-type and (b) 24B–Notch*
embryos. Subsets of muscles and motor neurons express
characteristic proteins: green, connectin; blue, isl-τ-myc reporter;
yellow, Vestigial. All motor axons also express fasciclin II (red).
Connectin-expressing muscles are innervated by connectin-positive
axons. ISNb is labelled by isl-τ-myc and innervates Vestigial-expressing
ventral longitudinal muscles. Anterior is to the left, dorsal is uppermost.
Muscle nomenclature shown is as described [3]: DA, dorsal; LL, lateral
longitudinal; LT, lateral transverse; SBM, segment border muscle;
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domains may regulate the growth-cone cytoskeleton in
response to such interactions [31,32].
Our results suggest a model in which motor axons are
sorted into distinct bundles by differential expression of
beaten path and nerve-branch-specific homophilic cell adhe-
sion molecules (Figure 4). Founder-myoblast-specific cues
act, possibly through receptor tyrosine phosphatases, to
trigger local changes in general interaxonal adhesion.
These changes alter the balance of forces, allowing specific
groups of axons to respond preferentially to cues in the
muscle field, thereby triggering the formation of a branch.
Materials and methods 
The fly stocks that were used were Oregon-R and
Df(2R)P520/mef222–21 (courtesy of H.T. Nguyen; [19]). The isl-τ-myc
reporter construct, which labels ISNb axons [16], was kindly provided
by S. Thor. We used 24BGAL4 [13] as a mesoderm driver (at 29°C)
for 24B–Notch* (UASNIntra1790 [12]; courtesy of T. Lieber). Antibody
stainings were performed as previously described [4]; the mouse anti-
connectin monoclonal antibody C1.427 (kindly provided by R. White
[14]) was diluted 1:10, the mouse anti-fasciclin II monoclonal antibody
1D4 and the mouse anti fasciclin III monoclonal antibody 2D5 (cour-
tesy of C. Goodman [8,33]) were both diluted 1:5, the rabbit anti-
myosin antibody (kindly provided by D. Kiehart [34]) was diluted 1:500,
the mouse anti-Myc antibody (Oncogene Science) was diluted 1:200,
and the rabbit anti-Vestigial antibody (kindly provided by S. Carroll
[21]) was diluted 1:1000.
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